Abbott expects to launch its first pulsed field ablation (PFA) device outside of the U.S. in 2025, CEO Robert Ford told investors on Wednesday. A company spokesperson said Abbott expects to ...

The instructions for use have been updated to address issues that led to a greater risk of neurovascular events in an early ...

A pair of investor calls on Jan. 22 added clarity to the rapidly evolving cardiac ablation market with Abbott Laboratories and Johnson & Johnson providing updates on their pulsed field ablation ...

J&J said it found no immediate procedure-related causes from the atrial fibrillation therapy but that risks can escalate if a ...

The Clarivate e-book highlights new medtech breakthroughs in the pulsed field ablation (PFA) market, forecasting its future growth and showcasing the technology's potential to transform the ...

Abbott Laboratories, the last of the big four players in ... market value and capture more than 70% of the global atrial fibrillation market by 2028. Pulsed Field Ablation: Stunning Growth Shocks the ...